These two properties of eK8 could represent key molecular mechanisms leading to the formation of metastases, making eK8 a relevant target in colorectal cancer, including KRAS-mutant diseases that are associated with resistance to EGFR inhibition. Here, EGFR is linked to colorectal cancer.